Sleep Disorders Trial, Recruiting (NCT05576090)

Sleep Disorders Trial, Recruiting NCT05576090 Sponsor: University of California, Los Angeles Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT05576090 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are in their first or second year of undergraduate study at UCLA
People between 18 and 22 years old
People who are currently living in the residential halls on the UCLA campus
People who score 8 or above on a standard sleep questionnaire called the Insomnia Severity Index, which suggests at least some level of sleep disturbance

Who may not be able to join:

People who have a current diagnosis of a mood or anxiety disorder, or who score 15 or above on either of two standard mental health questionnaires used in the study (the PHQ-8 or the GAD-7)
People who have a medical condition, or who take medications, that may affect sleep or the body's inflammation levels — for example, an autoimmune disorder (confirm with trial site)
People who have previously completed, or are currently enrolled in, a formal mindfulness meditation program (such as MAPs or MBSR) or a sleep education program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julienne E Bower, Ph.D., University of California, Los Angeles

Phone: (310) 975-9035

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05576090

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: (310) 975-9035

More information: https://clinicaltrials.gov/study/NCT05576090

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are in their first or second year of undergraduate study at UCLA
People between 18 and 22 years old
People who are currently living in the residential halls on the UCLA campus
People who score 8 or above on a standard sleep questionnaire called the Insomnia Severity Index, which suggests at least some level of sleep disturbance

Who may not be able to join:

People who have a current diagnosis of a mood or anxiety disorder, or who score 15 or above on either of two standard mental health questionnaires used in the study (the PHQ-8 or the GAD-7)
People who have a medical condition, or who take medications, that may affect sleep or the body's inflammation levels — for example, an autoimmune disorder (confirm with trial site)
People who have previously completed, or are currently enrolled in, a formal mindfulness meditation program (such as MAPs or MBSR) or a sleep education program

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

3 April 2023

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in sleep quality from baseline to post-intervention on the Pittsburgh Sleep Quality Index (PSQI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov